[1]张宏强,李桂霞,章彩凤,等.许筠治疗慢性肾病临床药对举隅*[J].陕西中医,2020,(6):808-810.[doi:DOI:10.3969/j.issn.10007369.2020.06.031]
点击复制

许筠治疗慢性肾病临床药对举隅*
分享到:

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2020年6期
页码:
808-810
栏目:
名老中医经验
出版日期:
2020-06-01

文章信息/Info

作者:
张宏强1李桂霞2章彩凤1范文静1许 筠3△
1.甘肃中医药大学(兰州 730000); 2.兰州市第二人民医院(兰州 730046); 3.兰州市第一人民医院(兰州 730050)
关键词:
慢性肾脏病 本虚湿瘀 当归补血汤 蛭龙胶囊 药对 许筠
分类号:
R256.5
DOI:
DOI:10.3969/j.issn.10007369.2020.06.031
文献标志码:
A
摘要:
许筠主任医师业医行道已30余载,临床经验丰富,在遣方用药方面独具特色,善抓主症,灵活运用药对,诊治各种肾脏疾病,屡起沉疴。导师认为慢性肾脏病其病机围绕“本虚湿瘀”衍生变幻,即病变以肺脾肾亏虚为主,早期肺肾气虚侧重,渐之脾肾亏虚,后期肺脾肾俱虚,且湿热瘀血全程缠绕,久之宿疾化生浊毒,积弊阻络沉疴。通过对导师以“本虚湿瘀”论治慢性肾脏病,临床常用黄芪与当归、女贞子与墨旱莲、泽兰与穿山龙、蝉蜕与僵蚕、水蛭与地龙、杜仲与牛膝等6对药对进行归纳总结,探寻导师用药规律及思路,传承其学术思想。

参考文献/References:

[1] 朱嘉欢,黄小平,邓常清.黄芪和当归的主要活性成分配伍促进衰老造血干细胞增殖作用的研究[J].中草药,2019,50(1):111-119.
[2] 罗慧英,黄亚红.当归挥发油对小鼠急性心肌缺血损伤的保护作用[J].中国现代应用药学,2016,33(2):159-162.
[3] 潘建科,陈海云,刘 军,等.中药防治髋部骨折深静脉血栓形成的用药规律研究[J].中医药导报,2017,23(8):58-61.
[4] 李竺娟,寇 炜,朱琳菊,等.当归红芪超滤物对顺铂诱导大鼠肾足细胞损伤的保护作用研究[J].重庆医学,2019,48(2):191-193.
[5] 李春梦,孙婷婷,刘 洋,等.经典名方二至丸基于网络药理学治疗糖尿病肾病机制探讨[J].中国中西医结合肾病杂志,2019,20(5):419-421.
[6] 刘其南,徐 佳,翟园园,等.二至丸对D-半乳糖诱导大鼠肾细胞衰老的保护作用[J].南京中医药大学学报,2018,34(1):81-86.
[7] 蔡秀江,黄美艳,丁安伟,等.二至丸考源及药理作用研究进展[J].中国实验方剂学杂志,2011,17(23):272-275.
[8] 许 筠.刘宝厚教授论治肾病临证经验摘萃[J].中国中西医结合肾病杂志,2008(4):285-287.
[9] 方 芳,顾媛媛,郭玉岩,等.穿山龙药理及临床研究[J].长春中医药大学学报,2018,34(3):450-452.
[10] 张丽莎.郁金和华泽兰的抗糖尿病化学成分研究[D].杭州:浙江大学,2018.
[11] 赵子佳,周桂荣,王 玉,等.蝉蜕的化学成分及药理作用研究[J].吉林中医药,2017,37(5):491-493.
[12] 俞 徽,张 茹,李桂霞,等.许筠主任医师祛瘀通络法结合象思维治疗慢性肾脏病经验[J].西部中医药,2017,30(11):64-66.
[13] 胡晓文,李桂霞,俞 徽,等.蛭龙胶囊对糖尿病肾病V期患者微炎症指标的影响[J].西部中医药,2017,30(4):88-90.

相似文献/References:

[1]屈 凯,王悦彤,王漱非,等.基于文献研究探讨益肾散结法防治肾小球硬化的理论内涵*[J].陕西中医,2019,(7):919.
 QU Kai,WANG Yuetong,WANG Shufei,et al.Based on literature research to explore the theoretical connotation of Kidney-reinforcing and Mass-disintegrating for prevention and treatment of glomerulosclerosis[J].,2019,(6):919.
[2]任永朋,华 琼,刘彦妍,等.中医“治未病”思想在防治肾脏病中的应用*[J].陕西中医,2019,(8):1101.
 REN Yongpeng,HUA Qiong,LIU Yanyan,et al.The application of the thought of “preventive treatment of disease” in the prevention and treatment of kidney disease in traditional Chinese medicine[J].,2019,(6):1101.
[3]陈紫薇,陈 明△.从脾论治慢性肾脏病的生物学基础探讨*[J].陕西中医,2020,(11):1627.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.029]
 CHEN Ziwei,CHEN Ming..Discuss the biological foundation for chronic disease therapy from treatment through the spleen[J].,2020,(6):1627.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.029]
[4]董 怡,马 静,余楠楠,等.大黄复方保留灌肠辅助治疗慢性肾脏病疗效及对患者生活质量的影响[J].陕西中医,2021,(7):910.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.026]
 DONG Yi,MA Jing,YU Nannan,et al.Effect analysis of rhubarb compound retention enema adjuvant treatment of chronic kidney disease and its impact on patients' quality of life[J].,2021,(6):910.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.026]
[5]齐 宁,宋姝西,刘香玉,等.参芪延肾方治疗慢性肾脏病疗效及对患者半乳糖缺陷IgA1、晚期糖基化终产物和微炎性反应状态的影响[J].陕西中医,2022,(5):596.[doi:DOI:10.3969/j.issn.1000-7369.2022.05.012]
 QI Ning,SONG Shuxi,LIU Xiangyu,et al.Effects of Shenqi Yanshen recipe on the levels of Gd-IgA1,AGEs and micro inflammatory response in patients with chronic kidney disease[J].,2022,(6):596.[doi:DOI:10.3969/j.issn.1000-7369.2022.05.012]
[6]麦芳雄,张香兰,朱德礼.温肾健脾清化汤辅助治疗脾肾气虚型慢性肾脏病疗效及对患者血清转化生长因子β1、纤维连接蛋白水平的影响[J].陕西中医,2022,(8):1068.[doi:DOI:10.3969/j.issn.1000-7369.2022.08.019]
 MAI Fangxiong,ZHANG Xianglan,ZHU Deli.Clinical efficacy of Wenshen Jianpi Qinghua decoction in the treatment of chronic kidney disease with spleen-kidney qi deficiency and its effect on serum transforming growth factor β1 and fibronectin levels[J].,2022,(6):1068.[doi:DOI:10.3969/j.issn.1000-7369.2022.08.019]
[7]杨淑彬,李 婷,李晓妮,等.不同中药结肠透析模式对慢性肾脏病患者胃肠道症状和营养状态的影响[J].陕西中医,2022,(12):1698.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.010]
 YANG Shubin,LI Ting,LI Xiaoni,et al.Effects of different colon dialysis modes of traditional Chinese medicine on gastrointestinal symptoms and nutritional status in patients with chronic kidney disease[J].,2022,(6):1698.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.010]
[8]陈 曦,董凯旋,周 荣,等.中药调控p38丝裂原活化蛋白激酶/核因子κB通路治疗肾纤维化研究进展[J].陕西中医,2023,(7):980.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.036]
 CHEN Xi,DONG Kaixuan,ZHOU Rong,et al.Research progress of traditional Chinese medicine regulating p38MAPK/NF-κB pathway in treatment of renal fibrosis[J].,2023,(6):980.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.036]
[9]周 林,禹 红,刘毓玲,等.活肾通络方联合依那普利对慢性肾脏病患者纤维化标志物、人附睾蛋白4水平的影响[J].陕西中医,2023,(10):1400.[doi:DOI:10.3969/j.issn.1000-7369.2023.10.014]
 ZHOU Lin,YU Hong,LIU Yuling,et al.Effect of Huoshen Tongluo decoction and enalapril on renal function,fibrosis markers and HE4 levels in patients with chronic renal disease[J].,2023,(6):1400.[doi:DOI:10.3969/j.issn.1000-7369.2023.10.014]
[10]王禹霖,刘梦超,郑冰洁,等.名中医张炳厚从瘀论治慢性肾脏病经验撷英[J].陕西中医,2023,(11):1602.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.026]
 WANG Yulin,LIU Mengchao,ZHENG Bingjie,et al.Experience of famous Chinese doctor Zhang Binghou treating chronic kidney disease by Yu[J].,2023,(6):1602.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.026]

备注/Memo

备注/Memo:
*甘肃省中医药管理局科研项目(GZK-2019-72)
更新日期/Last Update: 2020-06-09